ResultsIQ

ResultsIQ › Latest results › Coromandel International Limited

Coromandel International Limited Q4 FY26 results press release summary

NSE: COROMANDEL · BSE: 506395

Results press release of 7 May 2026, summarised by AI from the filing.

Coromandel FY26 consolidated total income ₹31,827 cr, up 30%, PAT ₹1,898 cr, down 8%.

Key takeaways

  1. Guidance Fertiliser granulation capacity expansion project at Kakinada scheduled for completion by Q4 FY26-27.
  2. Change Commissioned 2000 TPD Sulphuric Acid plant and 650 TPD Phosphoric Acid plant at Kakinada in Q4.
  3. Driver Nutrient business registered 7% growth with sales of 4.3 million tons.
  4. Risk Supply disruptions, volatile raw material prices and sharp currency movements affected the operating environment.

Original filing on BSE

Coromandel International Limited Q1 FY27 results

As filed: Revenue ₹8,165 cr (+16% year on year), EBITDA ₹756 cr (−3% year on year), PAT ₹382 cr (−24% year on year), EBITDA margin 9.3% (−185 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹6,004 cr (+20% year on year), EBITDA ₹488 cr (+15% year on year), PAT ₹115 cr (−25% year on year), EBITDA margin 8.1% (−40 bps). Score 33 of 100, Below trend. Revenue and EBITDA growth were in line with the company's own trend; profit before exceptional items growth was below it. EBITDA margin fell 40 bps year on year. Other income 28% of PBT. Tax rate 50%. Revenue fell 32% from last quarter. Share price after the results: −11.0% in 29 days (Nifty 500: −2.9%).
  • Q3 FY26: Revenue ₹8,779 cr (+27% year on year), EBITDA ₹800 cr (+11% year on year), PAT ₹488 cr (−4% year on year), EBITDA margin 9.1% (−130 bps). Score 51 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA growth was in line with it; profit growth was below it. EBITDA margin fell 130 bps year on year. Revenue fell 9% from last quarter. Share price after the results: +1.2% in 29 days (Nifty 500: +0.4%).
  • Q2 FY26: Revenue ₹9,654 cr (+30% year on year), EBITDA ₹1,147 cr (+18% year on year), PAT ₹793 cr (+20% year on year), EBITDA margin 11.9% (−124 bps). Score 54 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin fell 124 bps year on year. Share price after the results: +5.7% in 29 days (Nifty 500: −0.1%).
  • Q1 FY26: Revenue ₹7,042 cr (+49% year on year), EBITDA ₹782 cr (+55% year on year), PAT ₹502 cr (+62% year on year), EBITDA margin 11.1% (+43 bps). Score 70 of 100, Above trend. Revenue growth was well above the company's own trend; EBITDA growth was above it; profit growth was in line with it. EBITDA margin rose 43 bps year on year. Profit fell 13% from last quarter. Share price after the results: +3.9% in 29 days (Nifty 500: −1.9%).
  • Q4 FY25: Revenue ₹4,988 cr (+27% year on year), EBITDA ₹425 cr (+56% year on year), PAT ₹578 cr (+72% year on year), EBITDA margin 8.5% (+154 bps). Score 73 of 100, Above trend. Revenue and profit before exceptional items growth were well above the company's own trend; EBITDA growth was above it. EBITDA margin rose 154 bps year on year. Revenue fell 28% from last quarter. Share price after the results: +3.4% in 29 days (Nifty 500: +3.5%).
  • Q3 FY25: Revenue ₹6,935 cr (+27% year on year), EBITDA ₹722 cr (+102% year on year), PAT ₹508 cr (+123% year on year), EBITDA margin 10.4% (+386 bps). Score 85 of 100, Above trend. Revenue, EBITDA and profit growth were well above the company's own trend. EBITDA margin rose 386 bps year on year. Revenue fell 7% from last quarter.
  • Q2 FY25: Revenue ₹7,433 cr (+6% year on year), EBITDA ₹975 cr (−8% year on year), PAT ₹659 cr (−13% year on year), EBITDA margin 13.1% (−202 bps). Score 28 of 100, Below trend. EBITDA margin fell 202 bps year on year. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Coromandel International Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.